China BCT Pharmacy Group Inc
China BCT Pharmacy Group, Inc., through its subsidiaries, operates as an integrated pharmaceutical company in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Retail Pharmacy, and Manufacturing Pharmacy. The Pharmaceutical Distribution segment purchases pharmaceutical products from suppliers and distributes them to hospitals, retail drug stores, oth… Read more
China BCT Pharmacy Group Inc (CNBI) - Net Assets
Latest net assets as of June 2013: $184.55 Million USD
Based on the latest financial reports, China BCT Pharmacy Group Inc (CNBI) has net assets worth $184.55 Million USD as of June 2013.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($299.39 Million) and total liabilities ($114.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $184.55 Million |
| % of Total Assets | 61.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | 480861.41% |
| 10-Year Change | N/A |
| Growth Volatility | 82737.21 |
China BCT Pharmacy Group Inc - Net Assets Trend (2007–2012)
This chart illustrates how China BCT Pharmacy Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for China BCT Pharmacy Group Inc (2007–2012)
The table below shows the annual net assets of China BCT Pharmacy Group Inc from 2007 to 2012.
| Year | Net Assets | Change |
|---|---|---|
| 2012-12-31 | $134.27 Million | +15.23% |
| 2011-12-31 | $116.52 Million | +40.22% |
| 2010-12-31 | $83.10 Million | +55.68% |
| 2009-12-31 | $53.38 Million | +191110.45% |
| 2008-12-31 | $27.92K | +570.76% |
| 2007-12-31 | $-5.93K | -- |
Equity Component Analysis
This analysis shows how different components contribute to China BCT Pharmacy Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9726050800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2012)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $97.24 Million | 72.42% |
| Common Stock | $38.15K | 0.03% |
| Other Comprehensive Income | $10.03 Million | 7.47% |
| Other Components | $26.96 Million | 20.08% |
| Total Equity | $134.27 Million | 100.00% |
China BCT Pharmacy Group Inc Competitors by Market Cap
The table below lists competitors of China BCT Pharmacy Group Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
US BioTec Inc
PINK:USBC
|
$0.96 |
|
Compliance Energy Corporation
OTCGREY:CPYCF
|
$0.96 |
|
Ormet Corporation
PINK:ORMTQ
|
$0.96 |
|
Consolidated Eco-Systems Inc
PINK:EXSO
|
$0.96 |
|
Piksel Inc
PINK:PIKL
|
$0.96 |
|
New Frontier Energy Inc
PINK:NFEI
|
$0.96 |
|
Rainforest Resources Inc
OTCQB:RRIF
|
$0.96 |
|
Supurva Healthcare Group Inc
PINK:SPRV
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China BCT Pharmacy Group Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2011 to 2012, total equity changed from 116,520,211 to 134,265,188, a change of 17,744,977 (15.2%).
- Net income of 21,050,927 contributed positively to equity growth.
- Dividend payments of 1,500,000 reduced retained earnings.
- Other comprehensive income increased equity by 1,118,386.
- Other factors decreased equity by 2,924,336.
Equity Change Factors (2011 to 2012)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $21.05 Million | +15.68% |
| Dividends Paid | $1.50 Million | -1.12% |
| Other Comprehensive Income | $1.12 Million | +0.83% |
| Other Changes | $-2.92 Million | -2.18% |
| Total Change | $- | 15.23% |
Book Value vs Market Value Analysis
This analysis compares China BCT Pharmacy Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | $0.00 | $0.00 | x |
| 2008-12-31 | $0.01 | $0.00 | x |
| 2009-12-31 | $1.67 | $0.00 | x |
| 2010-12-31 | $2.16 | $0.00 | x |
| 2011-12-31 | $3.05 | $0.00 | x |
| 2012-12-31 | $3.52 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China BCT Pharmacy Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.68%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.70%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 1.82x
- Recent ROE (15.68%) is above the historical average (9.24%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-15.30K |
| 2008 | -54.28% | 0.00% | 0.00x | 1.05x | $-17.95K |
| 2009 | 36.36% | 14.26% | 1.46x | 1.74x | $14.07 Million |
| 2010 | 30.91% | 12.79% | 1.42x | 1.70x | $17.38 Million |
| 2011 | 26.77% | 12.11% | 1.21x | 1.82x | $19.54 Million |
| 2012 | 15.68% | 8.70% | 0.99x | 1.82x | $7.62 Million |
Industry Comparison
This section compares China BCT Pharmacy Group Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $250,857,268
- Average return on equity (ROE) among peers: -8.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China BCT Pharmacy Group Inc (CNBI) | $184.55 Million | 0.00% | 0.62x | $0.96 |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |